These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone. Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772 [No Abstract] [Full Text] [Related]
11. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium? Hladovec J Thromb Haemost; 1979 Jun; 41(4):474-8. PubMed ID: 483235 [TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of inhibitors of platelet release and aggregation. Rosenberg JC; Sell TL Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838 [TBL] [Abstract][Full Text] [Related]
13. [Platelet aggregation inhibitors. Their possible use in pediatric pathology]. Zannino L; Salvadori G Minerva Pediatr; 1979 Jan; 31(2):153-69. PubMed ID: 379581 [No Abstract] [Full Text] [Related]
14. Pharmacological properties of drug inhibiting platelet aggregation. de Gaetano G Acta Clin Belg; 1975; 30(3):184-9. PubMed ID: 1231456 [No Abstract] [Full Text] [Related]
15. [Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results]. Birgens HS; Hansen MS Ugeskr Laeger; 1980 Jan; 142(5):306-9. PubMed ID: 6986701 [No Abstract] [Full Text] [Related]
16. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. de Gaetano G; Cerletti C; Bertelè V Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469 [No Abstract] [Full Text] [Related]